GeneReach Biotechnology Corporation Ltd. of Taichung City at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

GeneReach Biotechnology Corporation Ltd.

No. 19 Keyuan 2nd Road, Central Taiwan Science Park, Xitun Distr, 40763 Taichung City
Taiwan
Telephone +886 4 24639869
Fax +886 4 24638255
sales@genereachbiotech.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Taiwan External Trade Development Council (TAITRA)

Hall map

MEDICA 2021 hall map (Hall 16): stand C36

Fairground map

MEDICA 2021 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Our products

Product category: Polymerase chain reaction (PCR)

POCKIT™ Central Nucleic Acid Analyzer

POCKIT™ Central Nucleic Acid Analyzer is based on automatic extraction system and iiPCR technology for in vitro diagnostic purpose*. Only 85 minutes from sample to answer for up to 8 samples, which is one of the leading systems around the world. The system has acquired TFDA and CE-IVD marking. 

*Not U.S. FDA cleared or approved yet.

Cost effective
    • Minimal hands-on time
    • Walk-away testing protocols
    • Better workflow management
    • STAT, increasing productivity

Easy to use
    • Minimal dexterity required
    • Preloaded ready-to-use cartridges
    • Universal pre-programmed protocols
    • Direct display of test results
    • User-friendly touch screen

Reliable
    • Proven iiPCR technology
    • Precise liquid handling
    • Built-in UV lamp for decontamination
    • Minimal human error and maintenance cost

More Less

Product category: Polymerase chain reaction (PCR)

POCKIT™ Central SARS-CoV-2 (orf 1ab) Premix Reagent

POCKIT™ Central SARS-CoV-2 (orf 1ab) Premix Reagent is intended for use with POCKIT™ Central system. The assay, targeting orf 1ab gene, is an in vitro diagnostic* molecular assay for qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oropharyngeal swab samples from patients suspected of SARS-CoV-2 infection (COVID-19) during the acute phase.

*Not U.S. FDA cleared or approved yet. 
 
Features
■ Cost effective
   - Minimal hands-on time
   - Walk-away molecular testing protocol 
   - Better workflow management
   - STAT, increasing productivity
■ User friendly
   - Minimal dexterity required
   - Preloaded ready-to-use cartridges
   - Universal pre-programmed protocol 
   - Direct display of test results
■ Reliable
   - Proven iiPCR* technology
   - Accurate results with internal control
    *insulated isothermal PCR 

Technical Information
■ POCKIT™ Central SARS-CoV-2 (orf 1ab) Premix Reagent
   Overall agreement..........................................97.0%
   Positive agreement.........................................96.8%
   Negative agreement.......................................97.1%
      *Compared to a SARS-CoV-2 real-time PCR assay

More Less

About us

Company portrait

GeneReach Biotechnology Corporation is dedicated to bringing the innovation to global health management. By developing, manufacturing and marketing products for applied nucleic acid detection technology, we offer pathogen detection platforms to multiple industries. The applications of our products include human health and animal health industries. The products are manufactured in compliance with the requirements of GMP in addition to ISO 13485.

Company data

Sales volume 200-499 Mio US $
Export content max. 75%
Number of employees 100-499
Area of business
  • Laboratory equipment
  • Diagnostic tests

Company information as a PDF file